Blair William & CO West Pharmaceutical Services Inc Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Blair William & CO holds 101,210 shares of WST stock, worth $31.8 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

101,210

Previous 112,520 10.05%

Holding current value

$31.8 Million

Previous $37.1 Million 18.03%

% of portfolio

0.09%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$277.16 - $333.3 $3.13 Million - $3.77 Million	-11,310 Reduced 10.05%	101,210 $30.4 Million
Q2 2024 Aug 12, 2024	BUY	$314.68 - $395.94 $3.35 Million - $4.22 Million	10,654 Added 10.46%	112,520 $37.1 Million
Q1 2024 May 09, 2024	BUY	$338.27 - $413.0 $395,775 - $483,210	1,170 Added 1.16%	101,866 $40.3 Million
Q4 2023 Feb 12, 2024	BUY	$318.29 - $392.21 $82,755 - $101,974	260 Added 0.26%	100,696 $35.5 Million
Q3 2023 Nov 09, 2023	SELL	$354.9 - $412.41 $148,703 - $172,799	-419 Reduced 0.42%	100,436 $37.7 Million
Q2 2023 Aug 11, 2023	SELL	$334.63 - $382.47 $694,357 - $793,625	-2,075 Reduced 2.02%	100,855 $38.6 Million
Q1 2023 May 12, 2023	BUY	$232.5 - $346.47 $1.05 Million - $1.57 Million	4,524 Added 4.6%	102,930 $35.7 Million
Q4 2022 Feb 10, 2023	SELL	$209.34 - $261.61 $888,020 - $1.11 Million	-4,242 Reduced 4.13%	98,406 $23.2 Million
Q3 2022 Nov 09, 2022	BUY	$246.08 - $343.65 $652,850 - $911,703	2,653 Added 2.65%	102,648 $25.3 Million
Q2 2022 Aug 10, 2022	BUY	$280.61 - $420.45 $179,029 - $268,247	638 Added 0.64%	99,995 $30.2 Million
Q1 2022 May 13, 2022	SELL	$357.49 - $445.92 $6.12 Million - $7.63 Million	-17,111 Reduced 14.69%	99,357 $40.8 Million
Q4 2021 Feb 14, 2022	SELL	$402.25 - $471.34 $412,708 - $483,594	-1,026 Reduced 0.87%	116,468 $54.6 Million
Q3 2021 Nov 12, 2021	SELL	$363.01 - $468.47 $4.02 Million - $5.19 Million	-11,068 Reduced 8.61%	117,494 $49.9 Million
Q2 2021 Aug 12, 2021	BUY	$284.77 - $363.2 $474,142 - $604,728	1,665 Added 1.31%	128,562 $46.2 Million
Q1 2021 May 13, 2021	BUY	$257.29 - $307.53 $217,924 - $260,477	847 Added 0.67%	126,897 $35.8 Million
Q4 2020 Feb 09, 2021	SELL	$261.16 - $301.66 $260,376 - $300,755	-997 Reduced 0.78%	126,050 $35.7 Million
Q3 2020 Nov 06, 2020	SELL	$224.99 - $288.02 $457,854 - $586,120	-2,035 Reduced 1.58%	127,047 $34.9 Million
Q2 2020 Aug 12, 2020	SELL	$149.8 - $227.17 $199,983 - $303,271	-1,335 Reduced 1.02%	129,082 $29.3 Million
Q1 2020 May 11, 2020	SELL	$128.96 - $174.76 $591,668 - $801,798	-4,588 Reduced 3.4%	130,417 $19.9 Million
Q4 2019 Feb 13, 2020	SELL	$137.6 - $151.21 $85,312 - $93,750	-620 Reduced 0.46%	135,005 $20.3 Million
Q3 2019 Nov 12, 2019	SELL	$121.41 - $150.02 $30,838 - $38,105	-254 Reduced 0.19%	135,625 $19.2 Million
Q2 2019 Aug 13, 2019	SELL	$111.27 - $125.15 $671,069 - $754,779	-6,031 Reduced 4.25%	135,879 $17 Million
Q1 2019 May 14, 2019	SELL	$94.53 - $110.2 $523,979 - $610,838	-5,543 Reduced 3.76%	141,910 $15.6 Million
Q4 2018 Feb 14, 2019	SELL	$93.0 - $123.98 $1.75 Million - $2.34 Million	-18,861 Reduced 11.34%	147,453 $14.5 Million
Q3 2018 Nov 13, 2018	SELL	$98.01 - $123.47 $257,472 - $324,355	-2,627 Reduced 1.55%	166,314 $20.5 Million
Q2 2018 Aug 13, 2018	SELL	$83.32 - $101.88 $1.1 Million - $1.35 Million	-13,246 Reduced 7.27%	168,941 $16.8 Million
Q1 2018 May 15, 2018	BUY	$85.56 - $102.4 $3.86 Million - $4.62 Million	45,110 Added 32.91%	182,187 $16.1 Million
Q4 2017 Feb 14, 2018	BUY	$91.65 - $101.65 $6.8 Million - $7.54 Million	74,162 Added 117.88%	137,077 $13.5 Million
Q3 2017 Nov 13, 2017	BUY	$84.54 - $96.75 $5.32 Million - $6.09 Million	62,915	62,915 $6.06 Million

Others Institutions Holding WST

# of Institutions

802

Shares Held

64.4M

Call Options Held

294K

Put Options Held

490K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $23.3B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account